【Block Rhythm】YZi Labs recently voiced on social media, blasting a series of actions by BNC(CEA Industries)'s board of directors. As an important shareholder of BNC, YZi Labs is dissatisfied with the board’s “poison pill plan” and charter amendments adopted in response to the written consent procedure initiated by YZi Labs.
According to YZi Labs, these board actions essentially obstruct shareholders from exercising their rights, with the purpose not being for the company’s benefit, but to maintain their own power. They also specifically criticized BNC’s board for postponing the 2025 annual meeting originally scheduled for December 17.
More interestingly, YZi Labs refuted BNC’s claim that they never considered alternative token strategies. They stated that BNC CEO David Namdar explicitly mentioned in an internal meeting in November 2025 whether to switch to assets like Solana. The implication is clear—the board is playing tai chi.
From the participants’ perspective, this turmoil involves a considerable lineup of figures. YZi Labs has submitted a preliminary consent statement to the SEC, planning to expand the board size and nominate director candidates of their own selection. The list includes not only Binance founder Changpeng Zhao(CZ), but also Max Baucus Sieben, David James Chapman and other industry figures. Currently, YZi Labs Management directly holds 2150481 shares of BNC common stock.
This governance dispute reflects the complexity of internal power balance in Web3 enterprises. The confrontation between shareholders and the board of directors relates to how to truly protect investor interests and maintain decision-making transparency. Subsequent developments are worth monitoring.
I notice this is Chinese text discussing what appears to be cryptocurrency or financial project governance issues, including mentions of "poison pill" tactics, board operations, shareholder interests, and management transparency concerns.
However, I should clarify my role: I'm designed to provide professional translations of cryptocurrency and Web3 content. This text appears to be informal commentary/discussion rather than formal content requiring professional translation.
If you need this translated to Japanese, here's the translation:
毒丸計画は本当にすごいですね。取締役会のこの操作は典型的な権力保護の態度で、株主の権益がこんなに明らかに空洞化されているのに否定するとは？
CZのグループはこのことを知っているはずですが、業界全体がこんな無茶苦茶なことに対して集団で対抗するべきです
BNCのこの問題はますます無茶苦茶になっていて、トークン戦略の嘘も帳尻が合わなくなっています
透明なガバナンスを約束したのに、結果は全て裏で操作されていた...だからこそ、私はずっとこの類のプロジェクトには手をつけません
年会を延期？直接ブラックリストに入れて会議を開かない方がむしろ正直かもしれませんね
BNC取締役会の「毒丸計画」が株主の波紋を呼び、CZなど複数の業界関係者が巻き込まれる
【Block Rhythm】YZi Labs recently voiced on social media, blasting a series of actions by BNC(CEA Industries)'s board of directors. As an important shareholder of BNC, YZi Labs is dissatisfied with the board’s “poison pill plan” and charter amendments adopted in response to the written consent procedure initiated by YZi Labs.
According to YZi Labs, these board actions essentially obstruct shareholders from exercising their rights, with the purpose not being for the company’s benefit, but to maintain their own power. They also specifically criticized BNC’s board for postponing the 2025 annual meeting originally scheduled for December 17.
More interestingly, YZi Labs refuted BNC’s claim that they never considered alternative token strategies. They stated that BNC CEO David Namdar explicitly mentioned in an internal meeting in November 2025 whether to switch to assets like Solana. The implication is clear—the board is playing tai chi.
From the participants’ perspective, this turmoil involves a considerable lineup of figures. YZi Labs has submitted a preliminary consent statement to the SEC, planning to expand the board size and nominate director candidates of their own selection. The list includes not only Binance founder Changpeng Zhao(CZ), but also Max Baucus Sieben, David James Chapman and other industry figures. Currently, YZi Labs Management directly holds 2150481 shares of BNC common stock.
This governance dispute reflects the complexity of internal power balance in Web3 enterprises. The confrontation between shareholders and the board of directors relates to how to truly protect investor interests and maintain decision-making transparency. Subsequent developments are worth monitoring.